The DOI matches its Crossref record; 147 of the 151 references it cites were found in a registry or an index.
Dystonia and parkinsonism
Abstract
Parkinsonism and dystonia may coexist in a number of neurodegenerative, genetic, toxic, and metabolic disorders and as a result of structural lesions in the basal ganglia. Parkinson's disease (PD) and the 'Parkinson-plus' syndromes (PPS) account for the majority of patients with the parkinsonism-dystonia combination. Dystonia, particularly when it involves the foot, may be the presenting sign of PD or PPS and these disorders should be suspected when adults present with isolated foot dystonia. Young age, female gender, and long disease duration are risk factors for PD-related dystonia, but dystonia in patients with PD is usually related to levodopa therapy. The mechanism of dystonia in PD is not well understood and the management is often challenging because levodopa and other dopaminergic agents may either improve or worsen dystonia. Other therapeutic strategies include oral medications (baclofen, anticholinergics and benzodiazepines), local injections of botulinum toxin, intrathecal baclofen, and surgical lesions or high frequency stimulation of the thalamus, globus pallidus, or subthalamus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but dystonic symptoms are mostly related to treatment, both medical and surgical (Jankovic and Tintner 2001).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Jankovic and Tintner 2001
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Progressive Supranuclear Palsy
Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-221 · Cited by 1,753
Association between Early-Onset Parkinson's Disease and Mutations in theParkinGene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J. R., Michele, G. D., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,489
The behavioural and motor consequences of focal lesions of the basal ganglia in man.
Bhatia, K., & Marsden, C. (1994) · Brain : a journal of neurology · doi:10.1093/brain/117.4.859 · Cited by 1,137
Graybiel, A. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00593-5 · Cited by 1,051
Pathophysiology of the basal ganglia in Parkinson's disease
Obeso, J. A., Rodríguez-Oroz, M. C., Rodrı́guez, M., Lanciego, J. L., Artieda, J., Gonzalo, N., & Olanow, C. W. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00028-8 · Cited by 874
The pathophysiology of primary dystonia
Berardelli, A. (1998) · Brain · doi:10.1093/brain/121.7.1195 · Cited by 832
Parkinson’s Disease and Movement Disorders
Tn, M., & Bhattacharyya, K. (2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587 · Cited by 802
Research works printed but not linked: 4
- Jankovic, 2000, Complications and limitations of drug therapy for movement disorders, 55, 52
- Fahn, 2000, The spectrum of levodopa-induced dyskinesias, Ann Neurol, 47, S52
- Segawa, 1976, Hereditary progressive dystonia with marked duiurnal variation, Adv in Neurology, 14, 215
- Walker, 2000, Intrathecal baclofen for dystonia: benefits and complications during six years of experience, Mov Disord, 15, 1242, 10.1002/1531-8257(200011)15:6<1242::AID-MDS1028>3.0.CO;2-Z · DOI
Cited by
Sorted by citations
The clinical symptoms of Parkinson's disease.
Sveinbjornsdottir, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13691 · Cited by 1,410
Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations
Jankovic, J. J. (2005) · Movement Disorders · doi:10.1002/mds.20458 · Cited by 549
Self-citationThe functional neuroanatomy of dystonia
Neychev, V. K., Gross, R. E., Lehéricy, S., Hess, E. J., & Jinnah, H. A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.026 · Cited by 473
Azher, S. N., & Jankovic, J. J. (2005) · Neurology · doi:10.1212/01.wnl.0000171857.09079.9f · Cited by 345
Self-citationAshour, R. R., & Jankovic, J. J. (2006) · Movement Disorders · doi:10.1002/mds.21058 · Cited by 231
Self-citationThe focal dystonias: Current views and challenges for future research
Jinnah, H. A., Berardelli, A., Comella, C., Defazio, G., DeLong, M. R., Factor, S. A., Galpern, W. R., Hallett, M., Ludlow, C. L., Perlmutter, J. S., et al. (2013) · Movement Disorders · doi:10.1002/mds.25567 · Cited by 210
Dystonia in Parkinson’s disease
Tolosa, E., & Compta, Y. (2006) · Journal of Neurology · doi:10.1007/s00415-006-7003-6 · Cited by 176
Respiratory problems in neurologic movement disorders
Mehanna, R., & Jankovic, J. J. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.07.004 · Cited by 171
Self-citationThe nature of postural tremor in Parkinson disease
Dirkx, M. F., Zach, H., Bloem, B. R., Hallett, M., & Helmich, R. C. G. (2018) · Neurology · doi:10.1212/wnl.0000000000005215 · Cited by 146
Levodopa strengths and weaknesses
Jankovic, J. J. (2002) · Neurology · doi:10.1212/wnl.58.suppl_1.s19 · Cited by 131
Self-citationStriatal deformities of the hand and foot in Parkinson's disease
Ashour, R. R., Tintner, R., & Jankovic, J. J. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70119-8 · Cited by 120
Self-citationDystonia and Parkinson's disease: What is the relationship?
Shetty, A. S., Bhatia, K. P., & Lang, A. E. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.001 · Cited by 111
The Anatomical Basis for Dystonia: The Motor Network Model
Jinnah, H. A., Neychev, V. K., & Hess, E. J. (2017) · PubMed Central · doi:10.7916/d8v69x3s · Cited by 100
The Cosmetic Use of Botulinum Toxin
Rohrich, R. J., Janis, J. E., Fagien, S., & Stuzin, J. M. (2003) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000082208.37239.5b · Cited by 91
Disease-oriented approach to botulinum toxin use
Jankovic, J. J. (2008) · Toxicon · doi:10.1016/j.toxicon.2008.11.013 · Cited by 89
Self-citationCamptocormia: the bent spine syndrome, an update
Lenoir, T., Guedj, N., Boulu, P., Guigui, P., & Benoist, M. (2010) · European Spine Journal · doi:10.1007/s00586-010-1370-5 · Cited by 79
Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective
Hagell, P., & Cenci, M. A. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.10.013 · Cited by 77
Gdynia, H., Sperfeld, A., Unrath, A., Ludolph, A. C., Sabolek, M., Storch, A., & Kassubek, J. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.06.003 · Cited by 76
Reversible Pisa syndrome in patients with Parkinson’s disease on dopaminergic therapy
Cannas, A., Solla, P., Floris, G., Tacconi, P., Serra, A., Piga, M., Marrosu, F., & Marrosu, M. G. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0072-6 · Cited by 75
Complicated recessive dystonia parkinsonism syndromes
Schneider, S. A., Bhatia, K. P., & Hardy, J. (2009) · Movement Disorders · doi:10.1002/mds.22314 · Cited by 75
Systematic clinical approach for diagnosing upper limb tremor
Wardt, J. V. D., van der Stouwe, A. M. M., Dirkx, M., Elting, J. W. J., Post, B., Tijssen, M. A., & Helmich, R. C. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322676 · Cited by 72
Hardesty, D. E., Maraganore, D. M., Matsumoto, J. Y., & Louis, E. D. (2004) · Movement Disorders · doi:10.1002/mds.20096 · Cited by 67
Parkinsonism and Related Disorders
Slow, E., & Lang, A. E. (2019) · DeckerMed Transitional Year Weekly Curriculum™ · doi:10.2310/tywc.1178 · Cited by 62
Motor symptoms in Parkinson's disease
Shahed, J. J., & Jankovic, J. J. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83013-2 · Cited by 60
Self-citationSheffield, J. K., & Jankovic, J. J. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.637 · Cited by 60
Self-citationAdult‐onset primary lower limb dystonia
Schneider, S. A., Edwards, M. J., Grill, S. E., Goldstein, S., Kanchana, S., Quinn, N. P., Bhatia, K. P., Hallett, M., & Reich, S. G. (2006) · Movement Disorders · doi:10.1002/mds.20794 · Cited by 59
Pathophysiological Concepts and Treatment of Camptocormia
Margraf, N. G., Wrede, A., Deuschl, G., & Schulz‐Schaeffer, W. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160836 · Cited by 59
Genetic animal models of dystonia: Common features and diversities
Richter, F., & Richter, A. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.07.002 · Cited by 56
Respiratory dysfunction in Parkinson's disease: a narrative review
D'Arrigo, A. M., Floro, S., Bartesaghi, F., Casellato, C., Papa, G. F. S., Centanni, S., Priori, A., & Bocci, T. (2020) · ERJ Open Research · doi:10.1183/23120541.00165-2020 · Cited by 58
Scoliosis in Patients with Parkinson's Disease
Baik, J. S., Kim, J. Y., Park, J. H., Han, S. W., Park, J. H., & Lee, M. S. (2009) · Journal of Clinical Neurology · doi:10.3988/jcn.2009.5.2.91 · Cited by 53
Rana, A.-Q., Kabir, A., Doğu, O., Patel, A. P., & Khondker, S. (2012) · European Neurology · doi:10.1159/000341621 · Cited by 54
Palliative Care in Amyotrophic Lateral Sclerosis, Parkinson's Disease, and Multiple Sclerosis
Elman, L. B., Houghton, D. J., Wu, G. F., Hurtig, H. I., Markowitz, C., & McCluskey, L. F. (2007) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9978 · Cited by 47
Treatment options for Parkinsonʼs disease
Tintner, R., & Jankovic, J. J. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200208000-00011 · Cited by 48
Self-citationClinical Analysis of Blepharospasm and Apraxia of Eyelid Opening in Patients with Parkinsonism
Yoon, W. T., Chung, E. J., Lee, S. H., Kim, B. J., & Lee, W. Y. (2005) · Journal of Clinical Neurology · doi:10.3988/jcn.2005.1.2.159 · Cited by 49
Postural, Bone, and Joint Disorders in Parkinson's Disease
Rabin, M., Earnhardt, M. C., Patel, A., Ganihong, I., & Kurlan, R. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12386 · Cited by 40
Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
Calabresi, P., & Standaert, D. G. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104579 · Cited by 39
Topography of essential tremor
Chen, W., Hopfner, F., Szymczak, S., Granert, O., Mueller, S. H., Kuhlenbäumer, G., & Deuschl, G. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.04.012 · Cited by 39
Hemiparkinsonism-hemiatrophy syndrome
Wijemanne, S., & Jankovic, J. J. (2007) · Neurology · doi:10.1212/01.wnl.0000277699.48155.39 · Cited by 36
Self-citationSun, Y.-N.-G., Tsai, P.-J., Chu, C.-L., Huang, W.-C., & Bee, Y.-S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209558 · Cited by 32
An Update on the Use of Botulinum Toxin Therapy in Parkinson’s Disease
Mills, R., Bahroo, L. B., & Pagán, F. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0511-3 · Cited by 35
Experimental Therapeutics for Dystonia
Jinnah, H. A., & Hess, E. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.01.001 · Cited by 33
Sleep disorders in Parkinson's disease
Thorpy, M. J. (2004) · Clinical cornerstone · doi:10.1016/s1098-3597(04)90013-0 · Cited by 33
Adult-onset primary focal foot dystonia
Singer, C., & Papapetropoulos, S. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.07.004 · Cited by 33
Clinical aspects of palliative care in advanced Parkinson’s disease
Lökk, J., & Delbari, A. (2012) · BMC Palliative Care · doi:10.1186/1472-684x-11-20 · Cited by 33
Dopamine agonists in Parkinson?s disease
Tintner, R., & Jankovic, J. J. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.11.1803 · Cited by 34
Self-citationTormenti, M. J., Tomycz, N. D., Coffman, K. A., Kondziolka, D. S., Crammond, D. J., & Tyler‐Kabara, E. C. (2011) · Journal of Neurosurgery Pediatrics · doi:10.3171/2011.3.peds10402 · Cited by 29
Hand, foot, and spine deformities in parkinsonian disorders
Wijemanne, S., & Jankovic, J. J. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01986-1 · Cited by 29
Self-citationSamizadeh, M., Fallah, H., Toomarisahzabi, M., Rezaei, F., Rahimi-Danesh, M., Akhondzadeh, S., & Vaseghi, S. (2023) · Brain Sciences · doi:10.3390/brainsci13060914 · Cited by 33
Association between male gender and pediatric essential tremor
Louis, E. D., Fernández‐Álvarez, E., Dure, L. S., Frucht, S. J., & Ford, B. (2005) · Movement Disorders · doi:10.1002/mds.20483 · Cited by 27
Yamada, K., Shinojima, N., Hamasaki, T., & Kuratsu, J. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310926 · Cited by 26
Pathophysiology and Clinical Assessment of Parkinsonian Symptoms and Signs
Jankovic, J. J. (2003) · CRC Press eBooks · doi:10.1201/9780203912164-8 · Cited by 26
Self-citationAnimal models for drug discovery in dystonia
Jinnah, H. A., Richter, A., Mink, J. W., Caldwell, G. A., Caldwell, K. A., Gonzalez‐Alegre, P., Cookson, M., Breakefield, X. O., DeLong, M. R., & Hess, E. J. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.1.83 · Cited by 25
Dressler, D. W. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52014-2.00038-0 · Cited by 23
Yoon, W. T. (2017) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2017.11.004 · Cited by 23
High-Frequency Pallidal Stimulation for Camptocormia in Parkinson Disease: Case Report
Thani, N. B., Bala, A., Kimber, T. E., & Lind, C. R. P. (2011) · Neurosurgery · doi:10.1227/neu.0b013e318210c859 · Cited by 23
Assessment of striatal & postural deformities in patients with Parkinson's disease
Pandey, S., & Kumar, H. N. M. (2016) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_502_15 · Cited by 17
Shroff, K., Caffall, Z. F., & Calakos, N. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105464 · Cited by 17
Postural & striatal deformities in Parkinson`s disease: Are these rare?
Pandey, S., & Garg, H. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.178577 · Cited by 17
Dystonia and other deformities in Parkinson's disease
Jankovic, J. J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.004 · Cited by 17
Self-citationStriatal hand in Parkinson’s disease: the re-evaluation of an old clinical sign
Spagnolo, F., Fichera, M., Bucello, S., Houdayer, E., Baroncini, D., Sarro, L., Leopizzi, E., Impellizzeri, M., Martinelli, V., Leocani, L., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7165-y · Cited by 16
Contribution of testosterone and estradiol in sexual dimorphism of early-onset Parkinson’s disease
Bovenzi, R., Conti, M., Simonetta, C., Bissacco, J., Mascioli, D., Michienzi, V., Pieri, M., Cerroni, R., Liguori, C., Pierantozzi, M., et al. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02811-0 · Cited by 15
Olson, J. W., Nakhmani, A., Irwin, Z. T., Edwards, L. J., Gonzalez, C. L., Wade, M. H., Black, S. D., Awad, M. Z., Kuhman, D. J., Hurt, C. P., et al. (2022) · Movement Disorders · doi:10.1002/mds.29057 · Cited by 13
High doses of botulinum toxin effectively treat disabling up-going toe
Kurtis, M. M., Floyd, A. G., Yu, Q., & Pullman, S. L. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.08.013 · Cited by 13
Pallidopyramidal disease: A misnomer?
Horstink, M. W. I. M., Dekker, M. C. J., Montagna, P., Bonifati, V., & van de Warrenburg, B. P. C. (2010) · Movement Disorders · doi:10.1002/mds.23118 · Cited by 11
Effects of Onabotulinum Toxin A on Gait in Parkinson’s Disease Patients with Foot Dystonia
Huang, P., Li, Y., Park, J. E., Huang, P. C., Xiao, Q., Wang, Y., Chen, S., Chen, S., Liu, J., & Wu, Y. (2021) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2021.42 · Cited by 12
Dyskinesias and Neural Grafting in Parkinson's Disease
Cenci, M. A., & Hagell, P. (2006) · Springer eBooks · doi:10.1007/0-387-32823-2_10 · Cited by 12
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00004-4 · Cited by 9
Self-citationAquino, C., Slow, E., & Lang, A. E. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12174 · Cited by 9
Cineradiographic analysis of respiratory movements in a mouse model for early Parkinson's disease
Campos, P. F., Hasegawa, K., Kumei, Y., & Zeredo, J. L. L. (2015) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2015.07.002 · Cited by 8
Treatment challenges in early stage Parkinson's disease
Tetrud, J. W. (2004) · Neurologic Clinics · doi:10.1016/j.ncl.2004.05.002 · Cited by 8
Paparella, G., Angelini, L., Cannizzo, V., Aloisio, S., Martini, A., Birreci, D., Costa, D. D., Riggi, M. D., Cannavacciuolo, A., & Bologna, M. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02861-4 · Cited by 7
Lökk, J., & Fereshtehnejad, S. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.9 · Cited by 7
From Collar to Coccyx: Truncal Movement Disorders: A Clinical Review
Colucci, F., Carvalho, V., Gonzalez‐Robles, C., Bhatia, K. P., & Mulroy, E. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13325 · Cited by 6
Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease
Pouclet, H., Derkinderen, P., & Lebouvier, T. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.05.016 · Cited by 6
Pathophysiology and clinical assessment
Jankovic, J. J., & Mehanna, R. (2013) · CRC Press eBooks · doi:10.1201/b14361-7 · Cited by 6
Self-citationDystonia and the pedunculopontine nucleus: Current evidences and potential mechanisms
Su, J., Hu, Y., Yang, Y., Li, R., Teng, F., Li, L., & Jin, L. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1065163 · Cited by 6
Paparella, G., Guerra, A., Galosi, S., Cannavacciuolo, A., Angelini, L., Popa, T., Berardelli, A., & Bologna, M. (2023) · Dystonia · doi:10.3389/dyst.2023.11448 · Cited by 5
Bajwa, J. A., Johnson, M. D., & Vitek, J. L. (2009) · Springer eBooks · doi:10.1007/978-3-540-69960-6_107 · Cited by 5
Allart, E., Rogeau, C., Grauwin, M. Y., Nachef, N., Lannes, X., Rousseaux, M., Thévenon, A., & Fontaine, C. (2015) · Orthopaedics & Traumatology Surgery & Research · doi:10.1016/j.otsr.2015.01.006 · Cited by 5
Understanding of skeletal deformities in Parkinson's disease
Baik, J. S. (2016) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1166_16 · Cited by 4
Dystonia and Parkinson’s disease: Do they have a shared biology?
Matar, E., & Bhatia, K. P. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.05.001 · Cited by 4
When the diagnosis is in the patient’s hand and in the neurologist’s eye
Bertini, A., Lenti, S., Libelli, G., Ronco, R., Oliveri, S., Montemagno, K., Priori, A., & Bocci, T. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07626-1 · Cited by 4
Botulinum Toxin Treatment in Parkinson’s Disease and Atypical Parkinsonian Disorders
Jindal, P., & Jankovic, J. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-56038-0_3 · Cited by 4
Self-citationCentral Pain and Complex Motoric Symptoms after Gosarelin Therapy of Prostate Cancer
Ernst, G., Gericke, A., & Berg, P. (2004) · The Scientific World JOURNAL · doi:10.1100/tsw.2004.197 · Cited by 4
Phenotypic comparison between combined dystonia-parkinsonism and idiopathic adult-onset dystonia
Idrissi, S., Erro, R., Mascia, M. M., Trinchillo, A., Esposito, M., Velucci, V., Pellicciari, R., Ceravolo, R., Cotelli, M. S., Schirinzi, T., et al. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02920-4 · Cited by 3
‘Diphasic’ levodopa-induced chorea in multiple system atrophy
Tan, E. K., & Chan, L. L. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00889.x · Cited by 3
Pathophysiology and clinical assessment
Jankovic, J. J., & Mehanna, R. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.004 · Cited by 3
Self-citationClinical Use of Botulinum Neurotoxin: Neuromuscular Disorders
Guidubaldi, A., Bentivoglio, A. R., & Albanese, A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0261-3_3 · Cited by 3
Postural deformities in patients with Parkinson disease (clinical and social aspects)
Fursova, I., Mikhailov, V. M., Захаров, Д. В., & Коваленко, А. П. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2019-4-2-112-117 · Cited by 2
A case of Parkinson’s disease following dystonia
Yasuda, C., Takei, T., UOZUMI, T., Toyota, T., Yuhi, T., & Adachi, H. (2016) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-000890 · Cited by 2
Shahed, J. J., & Jankovic, J. J. (2012) · CRC Press eBooks · doi:10.3109/9781841848525-4 · Cited by 2
Self-citationVitek, J. L. (2002) · Movement Disorders · Cited by 2
Molecular Mechanisms and Potential Biomarkers of Neuropsychiatric Disorders in Parkinson’s Disease
Owecki, W., Futyma, A., Kokorniak, O., Szczech, A., Słowikowski, B. K., Poszwa, J., Szymanowicz, O., Goutor, U., Jagodziński, P. P., Kozubski, W. P., et al. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin50055 · Cited by 1
Dopaminergic drug-induced jaw-opening dystonia in a patient with progressive supranuclear palsy
Tano, O., Kaneko, K., Kikuchi, A., Hasegawa, T., Takeda, A., & Aoki, M. (2013) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.53.308 · Cited by 1
Dystonia–Parkinsonism Syndromes
Teleg, E., & Rosales, R. L. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1516-9_6 · Cited by 1
Previous Injury and Chronic Pain are Associated with Side of Onset in Parkinson’s Disease
Tekin, I. (2015) · Journal of Neurology and Neurobiology · doi:10.16966/2379-7150.109 · Cited by 1
Dalvi, A., Lyons, K. E., & Pahwa, R. (2012) · Informa Healthcare eBooks · doi:10.3109/9781841848525.017 · Cited by 1
Striatal Toe: Too Harmless to Treat?
Jost, W. H., & Berberovic, E. (2025) · Toxins · doi:10.3390/toxins17040168 · Cited by 1
Levodopa-responsive retrocollis on the background of choreic dyskinesia
Kataoka, H., Sawada, Y., Shimozato, N., Inatomi, S., Yoshiji, H., & Sugie, K. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1692836 · Cited by 1
Treatment of Dystonic Pain with Botulinum Neurotoxins
Jabbari, B. (2022) · Springer eBooks · doi:10.1007/978-3-030-99650-5_12 · Cited by 1
Metadata
- Authors
- Jankovic, J., & Tintner, R.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Jankovic, Joseph
- ORCID
- Jankovic, Joseph
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 8
- Issue
- 2
- Pages
- 109-121
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W2113609048
- Cited by
- 135
- References
- 151
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 4 · 2013: 7 · 2012: 9
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Parkinsonism & Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
- Keywords
- dystonia, parkinsonism
- MeSH terms
- Antiparkinson Agents, Dystonia, Humans, Levodopa, Syndrome, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
